1,129
Views
6
CrossRef citations to date
0
Altmetric
Brief Report

Detection of human cytomegalovirus in synovial neutrophils obtained from patients with rheumatoid arthritis

, , , , , & show all
Pages 183-188 | Accepted 14 Sep 2020, Published online: 27 Nov 2020

References

  • Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity 2017;46:183–96.
  • Pierer M, Rothe K, Quandt D, Schulz A, Rossol M, Scholz R, et al. Association of anticytomegalovirus seropositivity with more severe joint destruction and more frequent joint surgery in rheumatoid arthritis. Arthritis Rheum 2012;64:1740–9.
  • Mocarski E, Shenk T. In: Field BN, Knipe DM, Howley PM, editors. Fields virology, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2007:2701–72.
  • Varani S, Frascaroli G, Landini MP, Soderberg-Naucler C. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity. Rev Med Virol 2009;69:131–45.
  • Stinski MF, Petrik DT. Functional roles of the human cytomegalovirus essential IE86 protein. Curr Top Microbiol Immunol 2008;325:133–52.
  • Mehraein Y, Lennerz C, Ehlhardt S, Remberger K, Ojak A, Zang KD. Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization. Mod Pathol 2004;17:781–9.
  • Skarman PJ, Rahbar A, Xie X, Soderberg-Naucler C. Induction of polymorphonuclear leukocyte response by human cytomegalovirus. Microbes Infect 2006;8:1592–601.
  • Gerna G, Percivalle E, Baldanti F, Sozzani S, Lanzarini P, Genini E, et al. Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol 2000;74:5629–38.
  • Larsson S, Soderberg-Naucler C, Wang FZ, Cytomegalovirus ME. DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 1998;38:271–8.
  • Litjens NHR, Huang L, Dedeoglu B, Meijers RWJ, Kwekkeboom J, Betjes MGH. Protective cytomegalovirus (CMV)-specific T-cell immunity is frequent in kidney transplant patients without serum anti-CMV antibodies. Front Immunol 2017;8:1137.
  • Kaneshiro K, Sakai Y, Suzuki K, Uchida K, Tateishi K, Terashima Y, et al. Interleukin-6 and tumour necrosis factor-alpha cooperatively promote cell cycle regulators and proliferate rheumatoid arthritis fibroblast-like synovial cells. Scand J Rheumatol 2019;48:353–61.
  • Gredmark-Russ S, Soderberg-Naucler C. Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology. Virulence 2012;3:621–34.
  • Maussang D, Langemeijer E, Fitzsimons CP, Stigter-van Walsum M, Dijkman R, Borg MK, et al. The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res 2009;69:2861–9.
  • Migita K, Arai T, Ishizuka N, Jiuchi Y, Sasaki Y, Izumi Y, et al. Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy. PLoS One 2013;8:e78699.
  • Kim SY, Solomon DH. Tumor necrosis factor blockade and the risk of viral infection. Nat Rev Rheumatol 2010;6:165–74.